Navigation Links
World's most endangered gorilla fights back
Date:12/5/2007

NEW YORK (December 5, 2007, 2007) In the wake of a study that documented for the first time the use of weaponry by Cross River gorillas to ward off threats by humans, the Wildlife Conservation Society announced today new field surveys to better protect this most endangered great ape.

The study, published earlier this year in the Journal of Primatology, found several instances of gorillas throwing sticks and clumps of grass when threatened by people. Gorillas usually flee and rarely charge when encountered by humans.

Cross River gorillas are restricted to Nigeria and Cameroon. They number only around 300 individuals, making them the most endangered of the four gorilla sub-species.

The Wildlife Conservation Society, which has studied Cross River gorillas since 1999, will begin new field surveys next month in an attempt to catalogue all potential gorilla habitat.

The surveys are being funded in part by the U.S. Fish and Wildlife Service.

Earlier this year, the Wildlife Conservation Society released an action plan to safeguard Cross River gorillas that included creating additional protected areas and raising awareness of this little known great ape. The observations of weapon-use took place in the proposed Kagwene Gorilla Sanctuary in Cameroon one of the new protected areas recommended in the report.

In 2005 the Wildlife Conservation Society documented the first case of tool use among gorillas when researchers discovered individuals using sticks to check the depth of streams before crossing them.


'/>"/>

Contact: Stephen Sautner
ssautner@wcs.org
718-220-3682
Wildlife Conservation Society
Source:Eurekalert

Page: 1

Related biology news :

1. The best both of worlds -- how to have sex and survive
2. Student study bolsters case for adding a rare sunflower to the endangered species list
3. Student study bolsters case for adding a rare sunflower to the endangered species list
4. Researchers discover forests of endangered tropical kelp
5. Critically endangered Amur leopard captured

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ts have at last worked out a way of using recordin...ird populations. This is the first time sound reco...d into accurate estimates of bird species, populat...ritish Ecological Society,s Journal of Applied Ec...ead to a major advance in our ability to monitor w...
(Date:11/26/2009)...thicillin-resistant Staphylococcus Aureus ) and o...on as low-temperature plasma prototype devices hav...failing bactericidal cocktails. , Two prototype ...infection of healthy skin (e.g. hands and feet) in...se a lethal threat; and another to shoot bacteria-...
(Date:11/25/2009)...mber 11, firefighters, police officers and ambulan... World Trade Center complex. They battled to save ...or survivors, tackled fires and evacuated as many ... estimated 17,000 people. And making their jobs ev...frightened workers and their relatives jammed mobi...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 1Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 2Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 3Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 4Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 5Reportlinker Adds Nosocomial Infections 3A Market Impact on Diagnostics and Therapeutics 3A 28MRSA HAP C diff and other Hospital Acquired Infectio 57998 6Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 1Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 2Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 3Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 4Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 5Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 6Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 7Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 8Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 1Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 2Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 3Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 4Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 5
...e believed to contain a toxic antimicrobial chemic...crutinized despite large scale,production and usag...sis conducted by researchers at the Johns Hopkins ...riclocarban, has been widely used for,decades in h...was,monitored for or detected in the environment. ...
...ease have surprised scientists with their ability ...brain plaques are removed.,Researchers at Washingt...cted mice with an antibody for a key component of ...n areas of the brain where,antibodies cleared plaq...nerve cell branches rapidly disappeared. , "These,...
...ease have surprised scientists with their ability ...brain plaques are removed.,Researchers at Washingt...cted mice with an antibody for a key component of ...n areas of the brain where,antibodies cleared plaq...nerve cell branches rapidly disappeared. , "These,...
Other Biology News:Anti-bacterial additive widespread in U.S. waterways 2Key molecule in plant photo-protection identified 2Key molecule in plant photo-protection identified 3Mouse brain cells rapidly recover after Alzheimer's plaques are cleared 2Mouse brain cells rapidly recover after Alzheimer's plaques are cleared 3
(Date:11/24/2009)...v. 24 Sigma-Aldrich Corp... NASDAQ OMX conference on Tuesday, December 1st at... parties may listen via live audio broadcast over ...g m a a ldrich.com/ . Users can click the "W...Sigma-Aldrich: Sigma-Aldrich is a leading Life S...
(Date:11/24/2009)...alif., Nov. 24 NeurogesX...ny focused on developing and commercializing novel...nthony DiTonno, President and Chief Executive Offi...per Jaffray Health Care Conference, to be held Dec...w York, New York. ,, Mr. DiTonno and Stephen G...
(Date:11/24/2009)...ficacy endpoint has been met for patients with adv...,, QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ ... (the "Company"), a global biopharmaceutical compa...y announced positive efficacy data from a Phase 2 ...e, AEZS-108 (formerly AN-152), in patients with ad...
(Date:11/24/2009)...Calif., Nov. 24 Genomic ... Randy Scott, Genomic Health,s Executive Chairman,...lth Care Conference in New York City on Tuesday, D... the live and subsequently archived webcast of the...n of Genomic Health,s website at http://investor....
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
..., , , , , , , Multip... , , Transformation Proto...01 , , , , , , ,... Organism , Neurospora crassa, ... Filamentous fungus, conidia, , ...
..., , , , , , , Multip..., , , , , , ...o. 4308 915.520 12/2001 , , , ..., , Microorganism , ... , Cell type , Bacteria, ...
..., , , , , , , Multip... , , Transfection Protoco... , , , , , , ,... Cell line , HeLa, human cervix epithel...Transfection with , Plasmid pEGFP-N1 (i...
Other Biology Technology:Neurospora crassa 2Listeria monocytogenes 2HeLa 2
Rabbit Anti-Human ADAM-12 (Meltrin alpha), carboxy terminal end Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-hnRNP F / H Monoclonal Antibody, Unconjugated, Clone 1G11 from Novus Biologicals
Rabbit Anti-MKK6, phospho (Ser207) Polyclonal Antibody, Unconjugated from Abcam
Custom Oligo Assay Single Locus 1920 samples from Illumina
Biology Products: